News & Views
GSK issues swine flu vaccine update
Apr 01 2010
In an update regarding the virus, GSK said it is working closely with governments from around the world to offer bespoke programmes for dealing with the issue.
"Pandemics by their nature are unpredictable and we recognise that governments needs are changing," it explained.
Earlier this year, the pharmaceutical giant said it started delivering two doses of the vaccine, but found high immune responses after lab testing to one of the medicines.
According to the firm, it continues to collect data regarding clinical trial programmes in relation to H1N1 medications and recently amended an existing agreement with Japan to deliver 68 per cent of ordered units.
The World Health Organization note laboratory-confirmed testing has revealed over 200 countries are experiencing swine flu cases.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 22 2024 Marrakech, Morroco
Making Pharmaceuticals Exhibition & Conference
Apr 23 2024 Coventry, UK
Apr 23 2024 Kintex, South Korea
Apr 23 2024 Seoul, South Korea
Apr 24 2024 Jakarta, Indonesia